Arcellx (ACLX) Other Non Operating Income (2021 - 2025)
Arcellx's (ACLX) quarterly Other Non Operating Income came in at $5.6 million in Q4 2025, down 25.94% year-on-year from $7.6 million in Q4 2024, and down 6.41% quarter-over-quarter from $6.0 million in Q3 2025.
Arcellx (ACLX) Other Non Operating Income (2021 - 2025) Analysis & Trends
Arcellx's Other Non Operating Income history runs 5 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- On a quarterly basis, Other Non Operating Income fell 25.94% year-over-year to $5.6 million in Q4 2025; TTM through Dec 2025 was $24.2 million, a 25.0% decrease from a year earlier, with the FY2025 full-year figure at $24.2 million, down 25.0% from the prior year.
- Other Non Operating Income fell to $5.6 million in Q4 2025 per ACLX's latest filing, from $6.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $8.6 million in Q1 2024 and bottomed at $1000.0 in Q1 2021.
- The 5-year median for Other Non Operating Income is $4.9 million (2023), against an average of $3.9 million.
- Across the five-year window, Other Non Operating Income jumped 51700.0% in 2022 and declined 26.41% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $28000.0 in 2021, then soared by 3514.29% to $1.0 million in 2022, then soared by 157.11% to $2.6 million in 2023, then jumped by 191.16% to $7.6 million in 2024, then slipped by 25.94% to $5.6 million in 2025.
- Per Business Quant, the three latest ACLX Other Non Operating Income figures stand at $5.6 million (Q4 2025), $6.0 million (Q3 2025), and $6.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.61 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 7.97 Mn |
| Jun 30, 2024 | 8.13 Mn |
| Mar 31, 2024 | 8.61 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 5.52 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 518,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |